Research on germs is now recognized as worthy by the Alzheimer's Association, reports Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.



[ad_1]

NAPLES, Fla., July 29, 2019 / PRNewswire / – Alzheimer's disease advocacy groups will pay more and more attention to research on microbes, which could contribute to Alzheimer's disease (AD), Leslie Norins, MD, PhD, CEO of Alzheimer's Germ Quest, Inc. He bases this belief on two developments from the recent "AAIC-2019" conference on Alzheimer's, in Los Angeles, sponsored by the Alzheimer's Association.

For the first time in recent years, a full session has been devoted to the possible roles of infectious agents. As a sign of growing interest in the subject, more than 500 researchers attended the conference.

Professor Ruth Itzhakiof Manchester and the Oxford Universities have examined the renewed interest in the herpes virus type 1, which it first evoked around 1990, but which had largely been ignored until recently.

Dr. Ben Readhead of University of the State of Arizona describes his evidence of brain tests involving herpes types 6 and 7. Harvard & # 39; s Dr. Robert Moir has examined his new theory that the particular protein, amyloid, found in the brains of AD patients does not constitute a "junk", as supposed, but is actually part of the immune response of the body to an invading microorganism.

According to Dr. Norins, the second notable event is the statement on infectious agents published by Dr. Maria Carrillo, Scientific Officer of the Alzheimer's Association. In particular, she said "it is becoming increasingly clear that microbes such as bacteria and viruses can play a role …"

Dr. Norins says it's the first time that he remembers that infectious agents have always been recognized by the Alzheimer's Association as legitimate research topics. "We hope that they will continue with research grants addressing these clues," he said.

According to Dr. Norins, other funders have shown increased support for finding infectious agents. The NIH's National Institute on Aging, which elevated this research to the rank of "high priority," used its exhibition booth for the conference to encourage grant applications. In addition, the American Society for the Fight against Infectious Diseases accepts applications for five $ 100,000 each.

Alzheimer's Germ Quest, Inc., is a public utility company headquartered in Naples, In Florida. It is privately funded and does not solicit or accept donations or external grants. He sponsors the "$ 1 million Challenge Award "for the scientist who can provide compelling evidence that a germ is at the origin of Alzheimer's disease.

SOURCE Alzheimer's Germ Quest, Inc.

Related Links

http://www.alzgerm.org

[ad_2]
Source link